PERT Consortium
Newsletter Signup

Receive updates on upcoming
conferences, latest pulmonary news
and articles on your email for free!

Pulmonary Embolism Symposium

What is Known and What We Need to Know

State of the Art, and Scientific Update

 

Pulmonary embolism (PE) is a life-threatening condition that affects people of all ages and health statuses, from the most fit athletes to the most infirm patients. Detection of PE, “the great masquerader,” is challenging because its signs and symptoms are often subtle and mimic those of other disease states. Once PE is diagnosed, clinicians have little guidance in choosing from the wide array of therapies available because:

  • No accepted algorithm exists to guide diagnostic and therapeutic decision making
  • Outcomes data and evaluation for available therapies are lacking
  • Care rendered to PE patients is fragmented among different clinical services
  • Assessment of bleeding and other risks remains daunting
  • Long-term effects of PE are poorly understood, though they can be severely debilitating

In the face of these challenges, multidisciplinary rapid-response programs promoting coordination among specialists who care for PE patients, such as the Pulmonary Embolism Response Team (PERT) initiative at Massachusetts General Hospital, are gaining traction. These initiatives hold the promise to:

  • Improve interdisciplinary communication and collaboration
  • Facilitate timely decision-making to enhance care
  • Enable systematic collection and evaluation of data related to PE treatment and outcomes

The purposes of this symposium are to improve PE diagnosis, care coordination, and treatment, while expanding our knowledge of the underlying mechanisms and long-term follow-up strategies for patients with PE.

 

PHYSICIAN CONTINUING EDUCATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Gaffney Events. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.

The CMEsolutions designates this live conference for a maximum of 12.60 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS TO RECEIVE CREDIT
To receive credit, participants must attend credit designated sessions, and must submit a completed evaluation and application for credit at the conclusion of the Pulmonary Embolism Symposium.

3rd Annual Pulmonary Embolism Symposium

A National Continuing Professional Education Event

June 23-24, 2017

The Royal Sonesta Boston

PULMONARY EMBOLISM

What is Known, and What We Need to Know
State of the Art and Scientific Update

Registration Now Open

PROGRAM OVERVIEW

7:00-8:00 REGISTRATION / CONTINENTAL BREAKFAST
8:00 Welcome and Opening Remarks —Christopher Kabrhel, MD
Block 1
8:15-9:15

Session 1 - Epidemiology and Risk Factors

8:15 The Epidemiology of PE­—Are We Making a Difference? ­—John A. Heit, MD
8:25 When Should We Suspect PE? —Jeffrey A. Kline, MD
8:35 Risk Assessment and the Pre-test Probability of PE —Philip Wells, MD
8:45 Whetting your Appetite with Some Challenging Cases —Victor Tapson, MD
8:55 Panel Discussion - Q & A with the Experts
9:15-10:15

Session 2 - Diagnosis and Imaging

9:15 What’s New in CT Pulmonary Angiography? —Brian B. Ghoshhajra, MD
9:25 Echocardiography—Diagnosis and Prognosis at the Bedside —David Dudzinski, MD
9:35 Venous Ultrasonography—Where Does It Fit For PE? —Ido Weinberg, MD
9:45 Diagnostic Algorithms—Bringing It All Together —Gregory Piazza, MD
9:55 Panel Discussion - Q & A with the Experts
10:15-10:30 A Patient’s Perspective
10:30-10:45 Break / Visit Exhibits
10:45-11:45

Session 3 - PE Severity and Risk Stratificiation

10:45 The Varied Impact of PE on Patient’s Lives —Ruth Morrison, RN, BSN
10:55 Tools for Risk Stratifying PE —David A. Slosky, MD
11:05 Low Risk PE—Is Outpatient Management an Option? —Geno J. Merli, MD
11:15 High Risk PE—The PERT Approach —Christopher Kabrhel, MD
11:25 Panel Discussion - Q & A with the Experts
11:45-1:00 PM Satellite Lunches
Block 2
1:00-2:00

Session 4 - Anticoagulation

1:00 Current regulatory environment and potential FDA role in furthering the goals of the PERT Consortium to improve outcomes for patients with PE and VTE —Jose Pablo Morales, MD
1:10 NOACs and Other Heparin Alternatives —Rachel P. Rosovsky, MD
1:20 NOAC Reversal Agents—Our Early Experience —George A. Davis, PharmD
1:30 Long Term Anticoagulation—How and For How Long? —John R. Bartholomew, MD
1:40 Panel Discussion - Q & A with the Experts
2:00-3:00

Session 5 - Thrombolysis, Catheters and Filters

2:00 IVC Filters: Who Needs Them and For How Long? —Michael R. Jaff, DO
2:10 Hemodynamic Collapse—Is Your Gestalt Good Enough to Empirically Lyse? —Belinda N. Rivera-Lebron, MD
2:20 Catheter Directed Thrombolysis—Have We Turned the Corner on a New Standard of Care? —Akhilesh Sista, MD
2:30 IV Thrombolysis—When, and For Whom? —Jeffrey W. Olin, MD
2:40 Panel Discussion - Q & A with the Experts
3:00-3:30 Break / Visit Exhibits
3:30-4:30

Session 6 - Surgery and ECMO

3:30 Suction Thrombectomy—New Devices, New Promise —Kenneth Rosenfield, MD
3:40 Open Surgical Thrombectomy —W. Brent Keeling, MD
3:50 Bridging PE Patients with ECMO —Emily Gundert, MD
4:00 What To Do When You See Clot in The Heart —Jay S. Giri, MD
4:10 Panel Discussion - Q & A with the Experts
5:00-5:30 Abstract & Poster Competition Moderator: Rachel Rosovsky
5:30-7:00 "A Evening with the the OPTALYSE Investigators" Reception Sponsored by: EKOS Corporation
7:00-8:00 AM Satellite Session
The Insiders guide to creating a Pulmonary Embolism Response Team
—Rachel Rosovsky, MD; Soophia Naydenov, MD; David Slosky, MD; George Davis, PharmD, BCPS
Sponsored by: PERT Consortium
7:00-8:00 REGISTRATION / CONTINENTAL BREAKFAST
8:00 Welcome and Opening Remarks —Christopher Kabrhel, MD
Block 3
8:15-9:15

Session 7 - Challenging PE Scenarios

8:15 Working Through the Cancer Patient With PE —Alok A. Khorona, MD
8:25 “My Patient Can’t Get Anticoagulated… Can They Get tPA?”—Treating Patients with High Bleeding Risk —Gustavo A. Heresi, MD
8:35 Critical Situations in the Cath Lab —Thomas M. Todoran, MD
8:45 Thrombotic Storm: HIT, TTP, APLS and Other Hypercoagulable States —Theodore Lee Ortel, MD, PhD
8:55 Panel Discussion - Q & A with the Experts
9:15-10:15

Session 8 - Long-Term PE Care and the Post-PE Syndrome

9:15 Post-Thrombotic Syndrome —Geoffrey D. Barnes, MD
9:25 Long-term Medication Adherence —John Fanikos, MBA, RPh
9:35 CTEPH - What Are Our Medical and Surgical Options? —Richard N. Channick, MD
9:45 Balloon Angioplasty - A New Frontier for Inoperable CTEPH —Rutger J. Lely, MD
9:55 Panel Discussion - Q & A with the Experts
10:15-10:45 Break / Visit Exhibits
10:45-11:45 Most Interesting PE Papers of the Year Moderator: Christopher Kabrhel, MD
11:45-1:00 PM Satellite Lunches
Block 4
1:00-2:15

Session 9 - Hands-On Workshops 1-4

Workshop 1: IVC Filter Symposium

-

Wish I Had Not Put In That Filter… —Kenneth Rosenfield, MD

-

My Most Difficult Filter Retrieval —T. Gregory Walker, MD

-

We Missed the Boat On Getting Out This Filter… —Ido Weinberg, MD

-

Too Sick To Move - Bedside Filter Placement —Christopher J. Kwolek, MD

-

Hands On: Filters, Snares, Forceps —Faculty

Workshop 2: CTEPH in Depth

-

A Tale of Three Patients… Who Is Right for BPA? —William R. Auger, MD

-

I Thought This Patient Would Do Better - A Non-Responder —Richard N. Channick, MD

-

Case Presentation 1 —Rutger J. Lely, MD

-

Case Presentation 2: Pressure and Image Guidance —Rutger J. Lely, MD

-

Interactive Case Studies —Faculty

Workshop 3: Suction Thrombectomy from A to Z

-

Three Different Cases, Three Different Devices —Robert Maholic, DO

-

We “Flip-Flopped” On This Case —Roy E. Smith, MD

-

En bloc Aspiration… It Just Might Work For PE —John Moriarty, MD

-

Hands On: Large and Small Bore Thrombectomy Devices —Faculty

Workshop 4: Creating a PERT Program that Works for Your Institution

-

How Our Team Works —Christopher Kabrhel, MD

-

PERT Activations - A Tale Of Three Cities —Alison S. Witkin, MD; Daniel R. Schimmel, Jr., MD; Charles B. Ross, MD

-

I Cannot Get This Team to Collaborate —Geoffrey D. Barnes, MD

-

Thank Goodness for Good Follow-Up on This Case —Rachel P. Rosovsky, MD

-

The PERT Consortium —Jana Montgomery, MD

-

Interactive - Creating a PERT —Faculty
2:15-2:45 Break / Visit Exhibits
2:45-4:00

Session 10 - Hands-On Workshops 5-8

Workshop 5: DVT Symposium

-

I Never Thought This DVT Would Embolize…Boy Was I Wrong! —Jeffrey W. Olin, DO

-

Is This Patient Safe Going Home? —Geno J. Merli, MD

-

Potpourri of Invasive Techniques —Robert M. Schainfeld, DO; Gregory Walker, MD

-

Case Example From the ATTRACT Trial —Akhilesh K. Sista, MD

-

Hands-on: DVT Devices —Faculty

Workshop 6: Our Most Surprising PERT Cases

-

Case Presentations —Roy E. Smith, MD, Andrew J.P. Klein, MD, Matthew D. Langston, MD, Josanna M. Rodriguez-Lopez, MD

-

Interactive: Lessons Learned —Faculty

Workshop 7: The PTSD of PE

-

The Depression and Anxiety of CTEPH: A Case Presentation —William R. Auger, MD

-

“Doc, Is This Gonna Happen Again and Will It Be the End?” —Mihir Kamdar, MD and Keri O. Brenner, MD, MPA

-

Early Psychological Intervention After Acute PE Can Work —Rachel P. Rosovsky, MD

-

Success Stories From Peer Support Groups —Ruth Morrison, RN, BSN

-

Interactive: Patient Perspectives —Invited Guests

Workshop 8: Massive PE—Hemodynamic Support, Lytics, and Open or Endovascular Thrombectomy

-

Patient Crashing In The ED - Full Dose Lytics or Is There Something Better? —Christopher Kabrhel, MD

-

A Clear Indication for Open Thrombectomy, but High Risk. What do to... —W. Brent Keeling, MD

-

Large-Bore Percutaneous Thrombectomy Using Veno-Veno Bypass. When and How? —John Moriarty, MD

-

ECMO in the Management of Massive PE —Nathalie Roy, MD

-

Recognizing the Need to Support the Failing RV —Mahir D. Elder, MD

-

Hands On: RV Impella, AngioVac, ECMO Pumps and Catheters —Faculty
4:00-4:10 Concluding Remarks

VISITING BOSTON

Boston, first incorporated as a town in 1630, and as a city in 1822, is one of America’s oldest cities, with a rich economic and social history. What began as a homesteading community eventually evolved into a center for social and political change. Boston has since become the economic and cultural hub of New England. Between our rich history, diverse neighborhoods, and legacy of arts, culture and education, Boston truly has something for everyone (and it’s easy to get around)!

As the region’s hub, Boston is home to over 617,000 residents, many institutions of higher education, some of the world’s finest inpatient hospitals, and numerous cultural and professional sports organizations. Boston-based jobs, primarily within the finance, health care, educational, and service areas, numbered nearly 660,000 in 2002. Millions of people visit Boston to take in its beautiful scenery, attend cultural or sporting events, and conduct business.

Visit City of Boston’s Official Website for more information

REGISTER LODGING

FACULTY LIST

Kenneth Rosenfield, MD, MHCDS
(Course Director)
Rachel P. Rosovsky, MD, MPH
(Course Director)
Samuel Z. Goldhaber, MD
(Course Director)
Christopher Kabrhel, MD, MPH
(Course Director)
Richard N. Channick, MD
(Course Director)